Axon Capital Private Medical Property Trust
Wholesale Investors Only

Axon Capital Private Medical Property Trust

Axon Capital Private Medical Property Trust
Axon Capital Private Medical Property Trust
|
Last Updated 01.07.2025

An exciting opportunity to invest into Toronto Private Hospital.

Axon Capital Private Medical Property Trust
Min. Investment
$50,000
Objective
Income
Structure
Managed Fund
Category
Property
Liquidity
Illiquid
Closing Date
11 July 2025
View More Details
Min. Investment
$50,000
Objective
Income
Structure
Managed Fund
Category
Property
Liquidity
Illiquid
Closing Date
11 July 2025
Industry
Property & Construction, Healthcare & Medical
Funding Stage
Unlisted Early-Stage Fund
Security Type
Unit in a trust
Target Capital
$22,000,000
Availability
Closing soon

Management Fees and Costs
0.40% p.a. + GST of GAV
Performance Fees
15% - 25% of outperformance of hurdles
Forecast Returns
15.0% p.a.
Investment Time Frame
4 Years (possibly longer subject to market)
Withdrawals
At end of Term
Distributions
Monthly

Axon Capital has secured the acquisition of Toronto Private Hospital, a 105-bed mental health and rehabilitation facility in the Hunter Region. This asset is leased to the leading national operator, Aurora Healthcare, for a remaining term of 18 years.

This opportunity allows for investment in critical healthcare infrastructure at a material discount to historical pricing and replacement cost. The acquisition is priced at $39.5 million, reflecting a favourable 6.9% capitalisation rate compared to the historic 5.0%. With current rent significantly below market rates, there is a clear pathway for growth.

The investment forecasts a 7.0% distribution yield and a 1.7x equity multiple over a four-year hold. This transaction represents a prime hospital acquisition in a post-COVID interest rate environment, acquired with clean capital and no legacy portfolio issues.

 

Axon Capital has secured an exciting opportunity to acquire Toronto Private Hospital, which is under contract. Toronto Private is a 105-bed, purpose-built mental health and rehabilitation facility located in the Hunter Region of NSW. The asset is leased on a net basis to Aurora Healthcare, a leading national operator with 17 hospitals and a strategic joint venture with Medibank Private (ASX: MPL).

The lease has 18 years remaining, with a significant market rent review in January 2028.

This opportunity exists because Australia’s core healthcare strategies are facing structural liquidity issues and balance sheet pressures that make it difficult for them to participate in acquisitions—providing selective opportunities with attractive economics at this point in the cycle:

  • Capitalisation rate: 6.9% (vs. historic 5.0%)
  • Purchase Price: $39.5 million
  • Rent/bed: $25,910 p.a. ($27,000-$32,000 p.a. market on conservative basis), compared to:
    • Market average (ex-Healthscope): $31,447 (+21%)
    • NSW average (ex-Healthscope): $33,443 (+29%)
    • Healthscope average: $45,402 (+75%)
  • Replacement cost: Estimated at ~$60.6 million (35–45% above purchase price)

Forecast fund returns follow:

  • 0% distribution yield (paid monthly)
  • 7x equity multiple / 15.0% IRR (base case) over a 4-year hold
  • Pathway to 2.0x equity multiple / 17.0% IRR in upside scenario

Toronto Private is a land-rich, operationally proven, and the only pure-play private mental health and rehabilitation hospital in the growing Hunter Region. Demand for such a facility is rising, driven by an aging population and a reported regional mental health incidence of 1 in 4 residents—above the state average.

This is the first prime hospital to transact since the post-COVID interest rate rebase. While many healthcare property managers are still carrying assets on book values around 5.0–5.5%, Axon is stepping into the market with clean capital and no legacy issues—acquiring critical healthcare infrastructure at a material discount.

Below is a summary of the key information regarding the hospital.


The lease is a whole of land lease structured as a net lease with a remaining term of ~18 years. 

  • 105 bed mental health and rehabilitation hospital
  • 18 credentialed staff specialising rehabilitation, mental health, robotic assisted therapy and palliative care
  • 71 car spaces for patients, staff and visitors

The tenant, Aurora Healthcare, operates a national portfolio of 17 private hospitals and is recognised as a leading specialist mental health and rehabilitation hospital operator.

 

The Property is: 

  • Generating net passing income of ~$2,720,000 which represents a ~6.9% passing yield based on the $39,500,000 gross purchase price 
  • Located at 241A Excelsior Parade, Toronto NSW 2283 (southern end of the Hunter Region) 
  • Occupied by Aurora Healthcare pursuant to a Lease that has an expiry date of 31 December 20321;  
  • A summary of the key lease terms can be found in Appendix 1; and 
  • Occupies 7,250 square meters of land and boasts 5,170 square meters of building area together with 71 car parks and 31 at grade parks for the strata medical centre.  

A summary of the key fund features follows:  

  • The transaction will be funded with: 
    • $21,725,000 of Australian bank debt (55% initial leverage); and  
    • $22,000,000 of investor equity.  
  • The Trust will have a fixed term of 4 years, although the Manager will have a right to extend the term if market conditions are not conducive to maximising the shareholders’ risk adjusted returns 
  • The fund is intended to be a single asset trust 
  • The fees are outlined in Section 3.12 of this document 

A summary of the key financial model assumptions used to estimate fund returns follows:  

  • Purchase price $39,500,000 
  • Passing income ~$2,720,000 
  • Debt and leverage: 
    • 7% spread over the swap curve 
    • Swap curve as provided by Westpac Bank on 22 April 2025 
  • CPI assumptions based on figures supplied by Westpac Bank on 22 April 2025 
  • Market rent review in December 2028 generating an increase in the passing rental by 5.0% meaning that: 
    • CPI would equal 3.0%; and 
    • Market determination of rental being 7.0%. 
  • The sale contract includes a retention of $1,250,000 set aside to meet the short to medium capital expenditure required at the Property, these funds will be used to fund the capital expenditure identified during due diligence 
  • A further ~$245,000 has been provisioned for in year 1 for capital expenditure; and 
  • Exit yield of 6.25%.

1 Including 2 x 5-year landlord options

Toronto Private Hospital is operated by Aurora Healthcare, one of Australia's foremost providers of mental health services. Aurora Healthcare is part of Luye Medical Group (HKEK:2186), a leading healthcare organization ranked among the top 10 service providers in the Asia-Pacific region.

The Toronto facility is one of 16 private hospitals under Aurora Healthcare's ownership. It features 105 beds and 18 credentialed staff, offering specialised services in rehabilitation, mental health, robotic-assisted therapy, and palliative care.

Aurora Healthcare operates across Australia, delivering high-quality care through its extensive network of hospitals and facilities. The group specialises in mental health, and rehabilitation services, ensuring a broad spectrum of patient needs are met. Its focus on patient-centric care and continuous improvement has established Aurora as a trusted name in the Australian healthcare landscape.

Aurora has established a relationship with major private health insurer Medibank (ASX:MPL) (AUD $7.85 billion in revenue in FY24). This affiliation enables Aurora to leverage international best practices, innovative technologies, and advanced medical systems, strengthening its ability to deliver exceptional healthcare outcomes across its portfolio.

Founded in 2025, Axon Capital is an investment management firm specialising in real estate private equity, with a deep passion for healthcare property.

Based in Australia, the firm seeks to take advantage of the compelling healthcare property opportunities in the market; buying properties such as leading national hospitals at a substantial discount to historical pricing.

The founder and managing director, Brendan See has worked at leading domestic medical property funds during significant growth in the sub sector. Further, Brendan’s background in managing distressed operating companies combined with his experience working in hospitals as well being part of a family that owns and operates medical facilities provides Axon Capital with a unique advantage to successfully invest in the sector.

The firm operates with a strong ethical foundation, rooted in the principles of the CFA Institute, reflecting founder Brendan See’s dedication to professionalism and investor-first practices. With over 20 years of experience in corporate finance and private markets, Brendan brings a proven track record of delivering successful outcomes across a wide range of transactions.

Axon Capital emphasises marketing leading investment strategies, leveraging extensive expertise in asset management, development, and direct investments. 

As a privately owned entity, Axon Capital is uniquely positioned to align its operations with the goals of its clients, fostering trust and long-term partnerships.



Brendan See has over 20 years of experience in financial services and private market investment management, specialising in corporate finance and real assets.

Brendan was part of the teams that grew the healthcare property strategies at Barwon Investment Partners and Australian Unity Investments from ~$190 million USD and $250 million USD to $1.25 billion and $1.90 billion USD, respectively.

He has worked on property and corporate transactions, served on the investment committee for a $400 million USD private credit strategy, and executed transactions exceeding $3.0 billion USD in healthcare property. His expertise spans public equity, private equity, and private debt, primarily in property, healthcare, and special situations.

Brendan’s roles include positions with leading healthcare real estate asset mangers, and with Deloitte. He led direct equity real estate strategies, managed development projects, and provided advisory services for transactions and restructurings.

Brendan holds a Bachelor of Business (Banking and Finance) from Queensland University of Technology, is a CFA Charterholder, and a Chartered Accountant.

Brendan is a National Committee Member for the CFA Society of Australia and Queensland Chapter Council Member for the CFA Society of Australia.

Qualifications:  B.Bus (Banking & Finance), CA, CFA

Click here to view our Information Memorandum.

Want to Talk to Someone?

Phone
By submitting this form, you agree to our Terms and Conditions and affirm you are a wholesale or sophisticated investor per the Corporations Act 2001
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Statutory Statement

This offer of scheme interests is available to wholesale clients only. This product listing was vetted by and approved by the product issuer identified above before publishing. Investment Markets (Aust) Pty Ltd AFSL 527875 (IM) is not the issuer of the product.

General Disclaimer

IMPORTANT STATEMENT ABOUT YOUR USE OF THIS SITE

Information on this site is intended for Australian users only.

This site is operated by Investment Markets (Aust) Pty Ltd. (ACN 634 057 248) (IMA, we, us and our), the holder of Australian Financial Services Licence (AFSL) no. 527875. The content is provided solely for information purposes, is not a recommendation or an offer to buy or sell a security, and is not warranted to be correct, complete or accurate. To the extent permitted by law, neither IMA, its affiliates, nor the content providers (such as the issuers of securities who appear on the site) are responsible for any investment decisions, damages or losses resulting from, or related to, the content, data and analyses or their use. The investment products on this site and any statements made about them by their issuers are not vetted, verified or researched by IMA. The presence of an investment product on this site should not be interpreted as an implied endorsement of it by IMA. Certain content provided may constitute a summary or extract of another document such as a Product Disclosure Statement. To the extent any content is general advice, it has been prepared by IMA. Any general advice has been provided without reference to your investment objectives, financial situations or needs. For more information refer to our Financial Services Guide. To obtain advice tailored to your situation, contact a financial advisor. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (or other offer document) before making any decision to invest. Past performance does not necessarily indicate an investment product’s future performance. The content is current as at date of initial publication and may not be current as at your date of viewing. For a more complete understanding of all the terms and conditions of your use of this site click here.

Subscribe to our newsletter

Elevate your investment game with our exclusive weekly newsletter, curated for astute investors like you. Dive into deep market insights and uncover a purposely broad range of unfiltered opportunities. Join a community that thrives on informed choices. Don't just follow the market—lead it.